XML 21 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 29, 2017
Oct. 30, 2016
Cash flows from operating activities:    
Net earnings $ 163,785 $ 160,760
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation and amortization 135,473 127,745
Loss on disposal/impairment of assets 1,299 1,852
Amortization of deferred lease incentives (18,987) (18,789)
Deferred income taxes (11,884) (14,461)
Tax benefit related to stock-based awards 15,439 23,571
Excess tax benefit related to stock-based awards   (4,817)
Stock-based compensation expense 30,164 37,975
Other (416) (647)
Changes in:    
Accounts receivable (2,341) (17,400)
Merchandise inventories (197,757) (82,410)
Prepaid catalog expenses 633 3,591
Prepaid expenses and other assets (20,001) (29,205)
Accounts payable 7,544 (17,403)
Accrued salaries, benefits and other liabilities (26,883) (507)
Customer deposits (5,815) (7,445)
Deferred rent and lease incentives 17,000 25,969
Income taxes payable 25,677 (65,915)
Net cash provided by operating activities 112,930 122,464
Cash flows from investing activities:    
Purchases of property and equipment (135,821) (127,169)
Other 458 370
Net cash used in investing activities (135,363) (126,799)
Cash flows from financing activities:    
Borrowings under revolving line of credit 170,000 125,000
Repurchases of common stock (154,321) (115,167)
Payment of dividends (101,928) (100,854)
Tax withholdings related to stock-based awards (14,836) (26,518)
Excess tax benefit related to stock-based awards   4,817
Proceeds related to stock-based awards   1,532
Other (20) (48)
Net cash used in financing activities (101,105) (111,238)
Effect of exchange rates on cash and cash equivalents 604 (2,693)
Net decrease in cash and cash equivalents (122,934) (118,266)
Cash and cash equivalents at beginning of period 213,713 193,647
Cash and cash equivalents at end of period $ 90,779 $ 75,381